Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease

OBJECTIVE: The aim was to demonstrate that continuous s.c. infusion of a soluble levodopa (LD)/carbidopa (CD) phosphate prodrug combination effectively delivers stable LD exposure via a minimally invasive and convenient mode and has the potential to treat Parkinson's disease (PD) patients who a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosebraugh, Matthew, Voight, Eric A., Moussa, Ehab M., Jameel, Feroz, Lou, Xiaochun, Zhang, Geoff G. Z., Mayer, Peter T., Stolarik, Deanne, Carr, Robert A., Enright, Brian P., Liu, Wei, Facheris, Maurizio F., Kym, Philip R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251848/
https://www.ncbi.nlm.nih.gov/pubmed/33772855
http://dx.doi.org/10.1002/ana.26073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251848/
https://www.ncbi.nlm.nih.gov/pubmed/33772855
http://dx.doi.org/10.1002/ana.26073

Ejemplares similares